AR016384A1 - Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta. - Google Patents
Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta.Info
- Publication number
- AR016384A1 AR016384A1 ARP980103699A ARP980103699A AR016384A1 AR 016384 A1 AR016384 A1 AR 016384A1 AR P980103699 A ARP980103699 A AR P980103699A AR P980103699 A ARP980103699 A AR P980103699A AR 016384 A1 AR016384 A1 AR 016384A1
- Authority
- AR
- Argentina
- Prior art keywords
- inhibitors
- caspasas
- alkyl
- apoptosis
- treatment
- Prior art date
Links
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 229910052757 nitrogen Inorganic materials 0.000 abstract 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 abstract 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 abstract 2
- 125000000008 (C1-C10) alkyl group Chemical group 0.000 abstract 1
- 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 230000006907 apoptotic process Effects 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 230000030833 cell death Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 125000004446 heteroarylalkyl group Chemical group 0.000 abstract 1
- 125000005842 heteroatom Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000011593 sulfur Chemical group 0.000 abstract 1
- 229910052717 sulfur Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Un compuesto que comprende la formula I en la que R1 es hidrogeno o alquilo C1-4; R2 alquilo C1-10, aril-alquilo C1-4 opcionalmente sustituido, heteroaril-alquilo C1-4 opcionalmente sustituido, cicloalquilo C3-7 opcionalmente sustituido, o R1 y R2 junto con el nitrogeno al que están unidos forman un anillo de 3 a10 miembros que contienen opcionalmente un heteroátomo adicional seleccionado entre nitrogeno o azufre; R3 y R4 son alquilo C1-6, hidrogeno, nitro o halogeno yR5 es alquilo C1-6, hidrogeno, arilalquilo o heteroarilalquilo, sus composiciones farmacéuticas y su uso para la preparacion de medicamentos utiles en eltratamiento de apoptosis , y de estados de enfermedad causados por una muerte celular excesiva o inapropiada.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5425597P | 1997-07-30 | 1997-07-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR016384A1 true AR016384A1 (es) | 2001-07-04 |
Family
ID=21989796
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103699A AR016384A1 (es) | 1997-07-30 | 1998-07-28 | Inhibidores de caspasas, composiciones farmaceuticas que comprenden dichos inhibidores de caspasas y uso de los inhibidores de caspasas para prepararun medicamento util para el tratamiento de apoptosis y desordenes asociados con excesiva actividad de la convertosa il-1 beta. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6403792B1 (es) |
| EP (1) | EP1001933A4 (es) |
| JP (1) | JP2001512100A (es) |
| AR (1) | AR016384A1 (es) |
| AU (1) | AU8763298A (es) |
| CA (1) | CA2297757A1 (es) |
| CO (1) | CO4970752A1 (es) |
| IL (1) | IL132770A0 (es) |
| WO (1) | WO1999006367A1 (es) |
| ZA (1) | ZA986760B (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR016551A1 (es) * | 1997-07-30 | 2001-07-25 | Smithkline Beecham Corp | Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos |
| CA2340100A1 (en) * | 1998-08-11 | 2000-02-24 | Daiichi Pharmaceutical Co., Ltd. | Novel sulfonyl derivatives |
| EP1242081A4 (en) * | 1999-09-30 | 2004-07-21 | Smithkline Beecham Corp | CASPASES AND APOPTOSIS |
| WO2001045716A1 (en) * | 1999-12-20 | 2001-06-28 | Gho'st Holding B.V. | Pharmaceutical composition comprising a physiologically acceptable vanadium compound, salt or complex and a na+/h+ exchange inhibitor |
| WO2001094311A1 (en) * | 2000-06-08 | 2001-12-13 | Mitsubishi Pharma Corporation | Cytoprotectors |
| SE0004780D0 (sv) | 2000-12-22 | 2000-12-22 | Jordanian Pharmaceutical Mfg & | Novel compunds |
| AT413485B (de) * | 2001-04-09 | 2006-03-15 | Hemoteq Gmbh | Mit einem pharmazeutikum beschichteter stent |
| US7009053B2 (en) | 2002-04-30 | 2006-03-07 | Yungjin Pharmaceuticals Co., Ltd. | Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| RU2232809C1 (ru) * | 2002-11-26 | 2004-07-20 | Институт органической химии им. Н.Д. Зелинского РАН | Способ прямого ингибирования каспаз |
| RU2233326C1 (ru) * | 2002-11-26 | 2004-07-27 | Институт органической химии им. Н.Д. Зелинского РАН | Способ ингибирования каспаз |
| GB0327494D0 (en) * | 2003-11-26 | 2003-12-31 | Amersham Plc | Novel imaging agents |
| US7256198B2 (en) | 2004-02-18 | 2007-08-14 | Wyeth | Pyrimidoindolones and methods for using same |
| GB0411056D0 (en) | 2004-05-18 | 2004-06-23 | Novartis Ag | Organic compounds |
| EP2202223B1 (en) * | 2007-10-18 | 2017-01-25 | Takeda Pharmaceutical Company Limited | Heterocyclic compound as blood rbp4 lowering agent |
| JP5667056B2 (ja) | 2008-09-05 | 2015-02-12 | インペリアル・イノベイションズ・リミテッド | インビボ画像化剤として使用されるイサチン誘導体 |
| ES3031438T3 (en) * | 2009-06-25 | 2025-07-08 | Alkermes Pharma Ireland Ltd | Heterocyclic compounds for the treatment of neurological and psychological disorders |
| WO2011137089A1 (en) | 2010-04-29 | 2011-11-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Activators of human pyruvate kinase |
| AU2012321345B2 (en) | 2011-10-03 | 2016-03-17 | The University Of Utah Research Foundation | Application of 5-HT6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
| CN103183631B (zh) * | 2011-12-28 | 2016-08-24 | 天津市国际生物医药联合研究院 | 靛红-5-磺酰胺类衍生物及其在制备治疗非典型性肺炎的药物中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE715760C (de) * | 1938-12-02 | 1942-01-07 | Ig Farbenindustrie Ag | Verfahren zur Herstellung von Sulfonamiden der Indolreihe |
| MC1357A1 (fr) * | 1979-12-07 | 1981-08-10 | Hoffmann La Roche | Derives de 2,3-indoledione |
| SE434638B (sv) | 1980-06-06 | 1984-08-06 | Lekemedelsfabriken Medica Ab | Nya terapeutiska verdefulla taurinderivat och deras framstellning |
| US5164404A (en) * | 1991-03-15 | 1992-11-17 | Neurosearch A/S | Hydrazone derivatives and their use |
| AU655643B2 (en) * | 1991-07-09 | 1995-01-05 | Neurosearch A/S | Novel isatineoxime derivatives, their preparation and use |
| US5728712A (en) | 1995-05-19 | 1998-03-17 | Chiroscience Limited | 3,4-disubstituted-phenylsulphonamides and their therapeutic use |
-
1998
- 1998-07-28 AR ARP980103699A patent/AR016384A1/es unknown
- 1998-07-29 ZA ZA986760A patent/ZA986760B/xx unknown
- 1998-07-29 CO CO98043133A patent/CO4970752A1/es unknown
- 1998-07-30 US US09/445,616 patent/US6403792B1/en not_active Expired - Fee Related
- 1998-07-30 JP JP2000505126A patent/JP2001512100A/ja not_active Withdrawn
- 1998-07-30 WO PCT/US1998/015935 patent/WO1999006367A1/en not_active Ceased
- 1998-07-30 IL IL13277098A patent/IL132770A0/xx unknown
- 1998-07-30 EP EP98939143A patent/EP1001933A4/en not_active Withdrawn
- 1998-07-30 AU AU87632/98A patent/AU8763298A/en not_active Abandoned
- 1998-07-30 CA CA002297757A patent/CA2297757A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ZA986760B (en) | 1999-02-01 |
| US6403792B1 (en) | 2002-06-11 |
| CA2297757A1 (en) | 1999-02-11 |
| CO4970752A1 (es) | 2000-11-07 |
| EP1001933A4 (en) | 2002-11-06 |
| AU8763298A (en) | 1999-02-22 |
| EP1001933A1 (en) | 2000-05-24 |
| IL132770A0 (en) | 2001-03-19 |
| JP2001512100A (ja) | 2001-08-21 |
| WO1999006367A1 (en) | 1999-02-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO872686D0 (no) | Nye farmakologiske forbindelser. | |
| SE8700499D0 (sv) | Novel pharmacologically active compounds | |
| ES2163407T3 (es) | Derivados piperidinilos tiaciclicos. | |
| AR007118A1 (es) | 4(3h)-quinazolinonas 2,3 disustituidas y composiciones farmaceuticas que las contienen | |
| SE0203654D0 (sv) | New compounds | |
| SE8804629D0 (sv) | New therapeutically active compounds | |
| ES2052603T3 (es) | Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen. | |
| PE20040411A1 (es) | Compuestos de aril cetona pirrolo triazina | |
| AR016551A1 (es) | Derivados de 2-oxindol, composiciones farmaceuticas que los comprenden y el uso de los mismos para la manufactura de medicamentos | |
| BR1100860A (pt) | Composto, droga antiinflamatória, composição farmacêutica, epìmero r e epìmero s do composto | |
| ES2082875T3 (es) | 3,5-di-terc-butil-4-hidroxifenilmetileno-derivados de tiazolidinonas, oxazolidinonas e imidazolidinonas 2-sustituidas utiles como agentes antiinflamatorios. | |
| ES2055860T3 (es) | Derivados 2-aminopirimidinona. | |
| PA8506301A1 (es) | Cristal de 4- carboxamino- 1,2,3,4,- tetrahidroquinolina 2-sustituida | |
| AR015222A1 (es) | Benzotiadiazoles, proceso para su preparacion, composicion farmaceutica que los contiene y su uso para la manufactura de un medicamento | |
| ATE66605T1 (de) | Waessrige arzneiformulierungen des piroxicammonohydrats. | |
| SE8404065D0 (sv) | Novel biologically active compounds | |
| MX9205123A (es) | Derivados de 5-hidroxi-2-pirimidinilmetileno utiles como agentes anti-inflamatorios. | |
| DK386986D0 (da) | Injicerbar halvfast farmaceutisk formulering med langsom frigivelse af den aktive bestanddel | |
| AR013152A1 (es) | Derivados de 2-alquilheterodihidropirimidina, proceso para su preparacion, composiciones farmaceuticas que contienen dichos derivados y el uso de dichosderivados y composiciones como ligandos para canales de calcio neuronales de tipo n. | |
| DK0652874T3 (da) | 2-heterocycliske-5-hydroxy-1,3-pyrimidiner der er nyttige som antiinflammatoriske midler | |
| DE3265838D1 (en) | (z)-1-aryl-2-aminomethyl-cyclopropane-carboxylates, their preparation and their use as medicines in the treatment of various disorders | |
| ES2038176T3 (es) | Un procedimiento para la preparacion de derivados del naftaleno. | |
| AR019322A1 (es) | Derivados de sulfonilo sustituido por heterociclo-etanodionanilina sustituida por heterociclo, composicion farmaceutica que los contiene y su uso para lamanufactura de un medicamento | |
| ES450799A1 (es) | Un procedimiento para la preparacion de nuevas 3-fenilespino(esobenzofuran-1,4'-piperidemo) sulfenamidas y derivados. | |
| IT8867891A0 (it) | Derivati terziobutilati di benzilidene canfora procedimento per la loro preparazione,loro impiego come agenti anti ossidanti e composizioni cosmetiche e farmaceutiche che li contengono |